Hoyle C - Search Results

1

Life-threatening infections occurring more than 3 months after BMT. 18 UK Bone Marrow Transplant Teams.

Hoyle C, Goldman JM. Hoyle C, et al. Bone Marrow Transplant. 1994 Aug;14(2):247-52. Bone Marrow Transplant. 1994. PMID: 7994240

2

Autografting for patients with chronic myeloid leukemia--the Hammersmith experience.

Mughal T, Hoyle C, Goldman JM. Mughal T, et al. Among authors: hoyle c. Stem Cells. 1993 Oct;11 Suppl 3:20-2. doi: 10.1002/stem.5530110907. Stem Cells. 1993. PMID: 8298473

3

Pyomyositis in a patient with myeloma responding to antibiotics alone.

Hoyle C, Goldman JM. Hoyle C, et al. J Intern Med. 1993 May;233(5):419-21. doi: 10.1111/j.1365-2796.1993.tb00694.x. J Intern Med. 1993. PMID: 8487008

4

Peripheral blood stem cell autografts in CML.

Hoyle C, Goldman J. Hoyle C, et al. Leuk Lymphoma. 1993;11 Suppl 1:271-5. doi: 10.3109/10428199309047898. Leuk Lymphoma. 1993. PMID: 7504545 Review.

5

Autografting for patients with CML in chronic phase: an update. Hammersmith BMT Team LRF Centre for Adult Leukaemia.

Hoyle C, Gray R, Goldman J. Hoyle C, et al. Br J Haematol. 1994 Jan;86(1):76-81. doi: 10.1111/j.1365-2141.1994.tb03255.x. Br J Haematol. 1994. PMID: 7912100

6

Dual infection with Pneumocystis carinii and respiratory viruses complicating bone marrow transplantation.

Lehner PJ, Rawal B, Hoyle C, Cohen J. Lehner PJ, et al. Among authors: hoyle c. Bone Marrow Transplant. 1992 Mar;9(3):213-5. Bone Marrow Transplant. 1992. PMID: 1324758

7

Second autologous transplant with cyclosporin/interferon alpha-induced graft versus host disease for patients who have failed first-line consolidation.

Streetly M, Kazmi M, Radia D, Hoyle C, Schey SA. Streetly M, et al. Among authors: hoyle c. Bone Marrow Transplant. 2004 Jun;33(11):1131-5. doi: 10.1038/sj.bmt.1704484. Bone Marrow Transplant. 2004. PMID: 15094743 Clinical Trial.

8

Can bone marrow transplantation be offered to more patients in south east Scotland?

Craig JI, Hoyle C, Yap PL, Parker AC. Craig JI, et al. Among authors: hoyle c. Scott Med J. 1988 Oct;33(5):326-8. doi: 10.1177/003693308803300504. Scott Med J. 1988. PMID: 3067350

9

The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.

Burnett AK, Milligan D, Goldstone A, Prentice A, McMullin MF, Dennis M, Sellwood E, Pallis M, Russell N, Hills RK, Wheatley K; United Kingdom National Cancer Research Institute Haematological Oncology Study Group. Burnett AK, et al. Br J Haematol. 2009 May;145(3):318-32. doi: 10.1111/j.1365-2141.2009.07604.x. Epub 2009 Mar 8. Br J Haematol. 2009. PMID: 19291085 Free article. Clinical Trial.

10

Acquired beta thalassaemia trait in MDS.

Hoyle C, Kaeda J, Leslie J, Luzzatto L. Hoyle C, et al. Br J Haematol. 1991 Sep;79(1):116-7. doi: 10.1111/j.1365-2141.1991.tb08017.x. Br J Haematol. 1991. PMID: 1911368 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters